Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects

Authors:

Abstract
Significance: C28, a chemical compound identified by computational screening, selectively facilitates voltage-dependent activation of a cardiac potassium ion channel, I Ks . This compound reverses drug-induced prolongation of the electric signals across the cardiac cell membrane known as action potentials (APs) but minimally affects the normal AP at the same dosage. This outcome supports a computational prediction that enhancing voltage-dependent activation of I Ks could be a potential therapy for AP prolongation. This therapy would increase the safety and expand the therapeutic efficacy of many currently approved drugs that induce AP prolongation, which can trigger life-threatening cardiac arrhythmias.
All Related Versions
Funding Information
  • HHS | NIH | National Heart, Lung, and Blood Institute (HL126774)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK108989)
  • HHS | NIH | National Institute of General Medical Sciences (GM109980)
  • HHS | NIH | National Institute of General Medical Sciences (GM136409)
  • American Heart Association (13GRNT16990076)
  • China Scholarship Council (201206380052)
  • HHS | NIH | U.S. National Library of Medicine (LM07089)

This publication has 53 references indexed in Scilit: